Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
| Autor: | Davey, Richard T, Jr., Collins, Gary L, Rouphael, Nadine, Poliquin, Guillaume, McConnell, Rosemary, Grubbs, Gabrielle, Moir, Susan L, Langley, Joanne M, Teitelbaum, Marc, Hewlett, Angela L, McLellan, Susan L F, Bhadelia, Nahid, Raabe, Vanessa N, Mulligan, Mark J, Maljkovic Berry, Irina, Dighero-Kemp, Bonnie, Kurtz, Jonathan R, Hensley, Lisa E, Dozier, Nelson C E, Marron, Lindsay C B, DuChene, Alain, Kuhn, Jens H, Brown, Shawn K, Khurana, Surender, Lane, H Clifford, Neaton, James D |
|---|---|
| Zdroj: | In The Lancet Microbe November 2024 5(11) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|